Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drowsy OTCs Match Rx Sleep Aids For Some Insomnia – Consumer Reports

This article was originally published in The Tan Sheet

Executive Summary

Newer insomnia treatments are no better than OTC antihistamines and older benzodiazepines, Consumer Reports says in its August 2006 "Best Buy Drugs" report

You may also be interested in...



Unisom May Benefit From FDA Concerns About Rx Competitors – Chattem

Chattem expects recent FDA concerns about the side effects of prescription sleep aids to offer a revenue boost to the Unisom line it recently acquired from Johnson & Johnson

Unisom May Benefit From FDA Concerns About Rx Competitors – Chattem

Chattem expects recent FDA concerns about the side effects of prescription sleep aids to offer a revenue boost to the Unisom line it recently acquired from Johnson & Johnson

Unisom May Benefit From FDA Concerns About Rx Competitors – Chattem

Chattem expects recent FDA concerns about the side effects of prescription sleep aids to offer a revenue boost to the Unisom line it recently acquired from Johnson & Johnson

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel